These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16822302)

  • 1. Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study.
    Worthington N; Markham Piper T; Galea S; Rosenthal D
    Harm Reduct J; 2006 Jul; 3():19. PubMed ID: 16822302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City.
    Galea S; Worthington N; Piper TM; Nandi VV; Curtis M; Rosenthal DM
    Addict Behav; 2006 May; 31(5):907-12. PubMed ID: 16139434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a naloxone distribution and administration program in New York City.
    Piper TM; Stancliff S; Rudenstine S; Sherman S; Nandi V; Clear A; Galea S
    Subst Use Misuse; 2008; 43(7):858-70. PubMed ID: 18570021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.
    Maxwell S; Bigg D; Stanczykiewicz K; Carlberg-Racich S
    J Addict Dis; 2006; 25(3):89-96. PubMed ID: 16956873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses.
    Strang J; Manning V; Mayet S; Best D; Titherington E; Santana L; Offor E; Semmler C
    Addiction; 2008 Oct; 103(10):1648-57. PubMed ID: 18821875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone--does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose.
    Neale J; Strang J
    Addiction; 2015 Oct; 110(10):1644-52. PubMed ID: 26119038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City.
    Piper TM; Rudenstine S; Stancliff S; Sherman S; Nandi V; Clear A; Galea S
    Harm Reduct J; 2007 Jan; 4():3. PubMed ID: 17254345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community Case Study of Naloxone Distribution by Hospital-Based Harm Reduction Program for People Who Use Drugs in New York City.
    Riazi F; Toribio W; Irani E; Hughes TM; Huxley-Reicher Z; McBratney E; Vu T; Sigel K; Weiss JJ
    Front Sociol; 2021; 6():619683. PubMed ID: 34307540
    [No Abstract]   [Full Text] [Related]  

  • 9. Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.
    Beletsky L; Ruthazer R; Macalino GE; Rich JD; Tan L; Burris S
    J Urban Health; 2007 Jan; 84(1):126-36. PubMed ID: 17146712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives.
    Tobin KE; Sherman SG; Beilenson P; Welsh C; Latkin CA
    Int J Drug Policy; 2009 Mar; 20(2):131-6. PubMed ID: 18434126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heroin overdose resuscitation with naloxone: patient uses own prescribed supply to save the life of a peer.
    Winston I; McDonald R; Tas B; Strang J
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of overdose prevention trainings in New York City: Knowledge and self-efficacy among participants 12 months after training.
    Maldjian L; Siegler A; Kunins HV
    Subst Abus; 2016; 37(3):459-465. PubMed ID: 26731134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.
    Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
    Addiction; 2015 Aug; 110(8):1301-10. PubMed ID: 25917125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overdose Education and Naloxone Distribution Program Attendees: Who Attends, What Do They Know, and How Do They Feel?
    Heavey SC; Burstein G; Moore C; Homish GG
    J Public Health Manag Pract; 2018; 24(1):63-68. PubMed ID: 28257406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
    McDonald R; Campbell ND; Strang J
    Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability.
    Strang J; Powis B; Best D; Vingoe L; Griffiths P; Taylor C; Welch S; Gossop M
    Addiction; 1999 Feb; 94(2):199-204. PubMed ID: 10396785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom.
    Langham S; Wright A; Kenworthy J; Grieve R; Dunlop WCN
    Value Health; 2018 Apr; 21(4):407-415. PubMed ID: 29680097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone use among overdose prevention trainees in New York City: A longitudinal cohort study.
    Siegler A; Huxley-Reicher Z; Maldjian L; Jordan R; Oliver C; Jakubowski A; Kunins HV
    Drug Alcohol Depend; 2017 Oct; 179():124-130. PubMed ID: 28772172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City.
    Coffin PO; Fuller C; Vadnai L; Blaney S; Galea S; Vlahov D
    J Urban Health; 2003 Jun; 80(2):288-90. PubMed ID: 12791804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.